Post-approval studies (Phase 4)Study completedNCT05704114
What this trial is testing
Tazarotene 0.045% Lotion for Treating PIE and PIH in Subjects With Acne
Who this might be right for
Acne VulgarisPost Inflammatory HyperpigmentationPost Inflammatory Pigmentation Change+2 more
Dr. Emmy Graber 20